| Old Articles: <Older 5511-5520 Newer> |
|---|
 |
The Motley Fool
March 24, 2009
Brian Orelli |
Taking the F Out of FDA President Barack Obama's nomination for deputy commissioner of the Food and Drug Administration has gotten people talking about the possibility of splitting the food safety portion away from the drug portion of the agency.   |
InternetNews
March 23, 2009
Kenneth Corbin |
Will Wireless IT Rescue Healthcare? Experts and advocates call for a new approach to healthcare that embraces wireless technology to lower costs. |
The Motley Fool
March 23, 2009
Brian Orelli |
Good News for Eli Lilly's Depression Drug Eli Lilly announces that the Food and Drug Administration has expanded the label of Symbyax to treat patients with treatment-resistant depression, meaning they haven't been helped by at least two other drugs. |
The Motley Fool
March 23, 2009
Brian Orelli |
Which Pharmas Still Have Cash? Pharmaceutical mergers-and-acquisitions activity has been jumping for the past few months, but the consolidation can't go on forever. |
The Motley Fool
March 20, 2009
Brian Orelli |
EU to Gilead: More Trials for You The U.S. isn't ready for Gilead Sciences' new cystic fibrosis drug, and neither is Europe. |
The Motley Fool
March 19, 2009
Brian Orelli |
Teva: An Equal-Opportunity Bully Making money by picking on the little guy, too. |
The Motley Fool
March 19, 2009
Brian Orelli |
One Down, One to Go Sanofi-aventis slides past an FDA panel and hopes for more good news today |
Fast Company
April 2009
Kate Rockwood |
Update Update on "Grand Experiment" article from February. |
The Motley Fool
March 18, 2009
Brian Orelli |
Merck Pummels Pfizer One of these acquisitions is not like the other. |
The Motley Fool
March 18, 2009
Brian Orelli |
Johnson & Johnson and Shakespeare The stage is set for a dramatic decision. |
| <Older 5511-5520 Newer> Return to current articles. |
